Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Inflammation × Febuxostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Inflammation 1 Hyperuricemia 1 Gout 1 Cardiovascular Diseases 1 Arthritis 1

Interventions

Omeprazole 2 soybean oil, phospholipid emulsion 1 dolutegravir 1 Vitamin D 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Sufentanil 1 Ritonavir 1 Riluzole 1 Oxycodone 1 Nutrition Assessment 1 Nucleosides 1 Naproxen 1 Fish Oils 1 Febuxostat 1 Exercise 1 Diet 1 Dexlansoprazole 1 Darunavir 1 Colchicine 1 Clindamycin 1 ClinOleic 1 Cephalexin 1 Anti-Bacterial Agents 1 Allopurinol 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed

196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡